Skip to main content

Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis

Fig. 1

Impact of obesity (a) and overweight status (b) on different outcomes after 1 year of treatment with a first TNFi in multivariable analyses. Summarized results from different multivariable models with the same covariates as used in Model 1 in Table 3. ASAS40 40% improvement according to the Assessment in SpondyloArthritis International Society criteria, ASAS-PR partial remission criteria according to ASAS, ASDAS Ankylosing Spondylitis Disease Activity Score, BASDAI-50 50% improvement in the Bath Ankylosing Spondylitis Disease Activity Index, BMI body mass index, CII clinically important improvement, MI major improvement

Back to article page